Sphera Funds Management Ltd. Aligos Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.48 - $17.69 $2.86 Million - $4.41 Million	-249,197 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.57 - $17.72 $3.63 Million - $4.42 Million	249,197 New	249,197 $3.87 Million
Q1 2021 May 17, 2021	SELL	$19.1 - $34.94 $1.41 Million - $2.59 Million	-74,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.2 - $32.74 $976,800 - $2.42 Million	74,000 New	74,000 $2.05 Million

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.